发明名称 |
ANALGESIC REGIMEN |
摘要 |
1. A regimen for the treatment of analgesia which comprises administering a pharmaceutical composition containing tramadol as the active ingredient which comprises: about 10-50 mg of tramadol on days 1-3; about 20-100 mg of tramadol on days 4-6; about 30-150 mg of tramadol on days 7-9; and about 40-400 mg of tramadol on days 10-28 and thereafter. 2. A regimen for the treatment of analgesia according to claim 1 which comprises administering a pharmaceutical composition containing tramadol as the active ingredient which comprises: about 10-50 mg of tramadol on days 1-3; about 20-100 mg of tramadol on days 4-6; about 30-150 mg of tramadol on days 7-9; and about 40-200 mg of tramadol on days 10-28 and thereafter. 3. A regimen for the treatment of analgesia according to claim 1 which comprises administering a pharmaceutical composition containing tramadol as the active ingredient which comprises: 25 mg of tramadol on days 1-3; 50 mg of tramadol on days 4-6; 75 mg of tramadol on days 7-9; 100 mg of tramadol on days 10-12; 150 mg of tramadol on days 13-15; and 200 mg of tramadol on days 16-28 and thereafter. 4. A regimen for the treatment of analgesia according to claim 1 which comprises administering a pharmaceutical composition containing tramadol as the active ingredient which comprises: 50 mg of tramadol on days 1-3; 100 mg of tramadol on days 4-6; 150 mg of tramadol on days 7-9; and 200 mg of tramadol on day 10 and thereafter. 5. A regimen for the treatment of analgesia according to claim 1 which comprises administering a pharmaceutical composition containing tramadol as the active ingredient which comprises: 25 mg of tramadol on days 1-3; 50 mg of tramadol on days 4-6; 75 mg of tramadol on days 7-9; 100 mg of tramadol on days 10-12; 150 mg of tramadol on days 13-15; and 200 mg of tramadol on day 16 and thereafter. 6. A regimen for the treatment of analgesia according to claim 1 which comprises administering a pharmaceutical composition containing tramadol as the active ingredient which comprises: 25 mg of tramadol q. d. on days 1-3, 25 of mg of tramadol b. i. d. on days 4-6, 25 mg of tramadol t. i. d. on days 7-9, 25 mg of tramadol q. i. d. on days 10-12, and 50 mg of tramadol t. i. d. on days 13-28. 7. The method of claim 1 wherein tramadol is administered in the form of tramadol hydrochloride.
|
申请公布号 |
EA003557(B1) |
申请公布日期 |
2003.06.26 |
申请号 |
EA20010000501 |
申请日期 |
1999.10.12 |
申请人 |
ORTHO-MCNEIL PHARMACEUTICAL, INC. |
发明人 |
KAMIN, MARC;OLSON, WILLIAM |
分类号 |
A61K31/135;A61P19/02;A61P25/04;(IPC1-7):A61K31/135 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|